Editor(s):
(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.
Reviewers:
(1) T. Usha Rani, KNR University of Health Sciences, India.
(2) Jelena Roganovic, Clinical Hospital Center Rijeka, Croatia.
Additional Reviewers:
(1) Vishal Vishnu Tewari, Maharashtra University of Health Sciences, India.
(2) Adamu Dalhatu, Bayero University kano, Nigeria.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.5/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (T. Usha Rani, India) | File 1 | File 2
Stage 2 | Peer review report_2 (Jelena Roganovic, Croatia) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA